Results 151 to 160 of about 1,220,791 (168)

Diva Vaccines That Reduce Virus Transmission

open access: yesJournal of Biotechnology, 1999
This brief review deals with the effect of diva (Differentiating Infected from VAccinated individuals) vaccines (also termed marker vaccines) on transmission of herpesviruses and pestiviruses in swine and cattle.
Jan T van Oirschot
exaly   +2 more sources

Efficacy of Chimeric Pestivirus Vaccine Candidates Against Classical Swine Fever: Protection and DIVA Characteristics

open access: yesVeterinary Microbiology, 2013
Currently no live DIVA (Differentiating Infected from Vaccinated Animals) vaccines against classical swine fever (CSF) are available. The aim of this study was to investigate whether chimeric pestivirus vaccine candidates (CP7_E2alf, Flc11 and Flc9) are ...
Sandra Blome   +2 more
exaly   +2 more sources

Development of a Competitive ELISA for NS3 Antibodies as DIVA Test Accompanying the Novel Disabled Infectious Single Animal (DISA) Vaccine for Bluetongue

open access: yesVaccine, 2015
Recently, we have developed a novel vaccine for Bluetongue named BT Disabled Infectious Single Animal (DISA) vaccine. Due to the lack of non-essential NS3/NS3a protein, BT DISA vaccine is a replicating vaccine, but without the inherent risks of live ...
Piet A van Rijn   +2 more
exaly   +2 more sources

Construction and efficacy of a new live chimeric C-strain vaccine with DIVA characteristics against classical swine fever.

Vaccine, 2023
To develop the new classical swine fever (CSF) vaccine candidate with differentiating infected vaccinated animals (DIVA) characteristics, a chimeric CSF virus (CSFV) was constructed based on an infectious cDNA clone of the CSF vaccine C-strain.
Weicheng Yi   +6 more
semanticscholar   +1 more source

Safety, efficacy, and DIVA feasibility on a novel live attenuated CSFV marker vaccine candidate.

Vaccine, 2022
Classical swine fever virus (CSFV) is the etiological agent of classical swine fever, a highly contagious disease that causes significant economic losses to the swine industry.
Chao Tong   +4 more
semanticscholar   +1 more source

Development of an inactivated H9N2 subtype avian influenza serological DIVA vaccine using the chimeric A/B NA epitope approach.

Veterinary Microbiology
Vaccination is a critical strategy for controlling H9N2 avian influenza, a subtype with significant implications for poultry health and public safety. Current vaccines hinder serological differentiation between naturally infected and vaccinated animals ...
Jingfeng Zhang   +7 more
semanticscholar   +1 more source

Diagnostic DIVA Tests Accompanying the Disabled Infectious Single Animal (DISA) Vaccine Platform for African Horse Sickness

open access: yesVaccine, 2018
African Horse Sickness Virus (AHSV) (Orbivirus genus, Reoviridae family) causes high mortality in naïve domestic horses with enormous economic and socio-emotional impact. There are nine AHSV serotypes showing limited cross neutralization.
Piet A van Rijn   +2 more
exaly   +2 more sources

A DIVA-compatible Mycobacterium bovis triple mutant vaccine confers protection against bovine tuberculosis in mouse model.

Veterinary Immunology and Immunopathology
Bovine tuberculosis (bTB) is a pulmonary infectious disease caused by Mycobacterium bovis, affecting cattle and a wide range of mammals, including humans.
F. Blanco   +9 more
semanticscholar   +1 more source

Immunogenicity, safety and dual DIVA-like character of a recombinant candidate vaccine against neosporosis in cattle.

Acta Tropica
Neosporosis is the major infectious cause of abortion and reproductive losses in cattle worldwide; however, there are no available vaccines or drugs to control this disease.
Luisa F. Mendoza-Morales   +11 more
semanticscholar   +1 more source

Chitosan nanoparticle based ΔgE IBRV Vaccine: A Novel DIVA compatible strategy for enhanced immunity in guinea pigs.

International journal of pharmaceutics
Infectious Bovine Rhinotracheitis (IBR), caused by Bovine Herpesvirus-1, is a significant disease in cattle that results in substantial economic losses worldwide.
N. Pawaskar   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy